Search Result "the target 90-90-90"


Letter to the Editor

How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?

Journal: Current HIV Research
Volume: 19 Issue: 2 Year: 2021 Page: 103-105
Author(s): Hayat Kumbasar Karaosmanoglu

Review Article

The Role of Heat Shock Protein -90 (HSP-90) in Inflammatory Disorders

Journal: Current Chemical Biology
Volume: 14 Issue: 1 Year: 2020 Page: 30-37
Author(s): Chiranjib Bhattacharjee,Lokesh Deb

Targeting Heat Shock Proteins 70/90 and Proteasome for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 4250-4264
Author(s): R. E. Wang

Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase

Journal: Current Drug Targets
Volume: 6 Issue: 3 Year: 2005 Page: 337-351
Author(s): A. Budillon, F. Bruzzese, E. Di Gennaro, M. Caraglia

Targeting Heat Shock Protein 90 for Malaria

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 13 Year: 2013 Page: 1903-1920
Author(s): Anup S. Ramdhave,Dhaval Patel,I. Ramya,Mukesh Nandave,Prashant S. Kharkar

Heat Shock Protein 90 Inhibitors as Therapeutic Agents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 7 Issue: 3 Year: 2012 Page: 313-336
Author(s): Isabel Gomez-Monterrey,Marina Sala,Simona Musella,Pietro Campiglia

Heat Shock Protein 90 Inhibitors in Oncology

Journal: Current Proteomics
Volume: 11 Issue: 1 Year: 2014 Page: 2-16
Author(s): Aykut Ozgur, Yusuf Tutar

The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target

Journal: Current Cancer Drug Targets
Volume: 8 Issue: 6 Year: 2008 Page: 522-535
Author(s): M. F. Barginear, C. Van Poznak, N. Rosen, S. Modi, C. A. Hudis, D. R. Budman

Standardization of Procedures for the Preparation of 177Lu- and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation

Journal: Current Radiopharmaceuticals
Volume: 8 Issue: 1 Year: 2015 Page: 62-68
Author(s): Wioletta Wojdowska,Urszula Karczmarczyk,Michal Maurin,Piotr Garnuszek,Renata Mikolajczak

Research Article

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 2 Year: 2016 Page: 160-168
Author(s): Parul Thakral,Suhas Singla,Atul Vashist,Madhav P. Yadav,Santosh K. Gupta,Jaya S. Tyagi,Atul Sharma,Chandra S. Bal,Snehlata,Arun Malhotra

Previous   Next

Go To   Results 1 - 1 of 10000

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy